José Antonio Baz

José Antonio Baz

Interventional cardiologist / Cardiologist
Hospital Alvaro Cunqueiro - Vigo, Spain

Latest contributions

Mitral regurgitation: from guidelines to clinical practice

16 Nov 2025 – From PCR London Valves 2025

This LIVE case symposium brings mitral regurgitation guidelines into real clinical practice. Through step-by-step patient demonstrations and insightful discussion, the session explores how recommendations guide decision-making in ventricular and atrial secondary MR, how the heart team tailors therapy to individual anatomy and comorbidities, and how device iterations...

Mitral regurgitation: from guidelines to clinical practice

Align for the future with next gen Myval transcatheter heart valve series

16 Nov 2025 – From PCR London Valves 2025

Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...

Align for the future with next gen Myval transcatheter heart valve series

Redo TAVI with pre and post dilatation - LIVE Case

16 Nov 2025 – From PCR London Valves 2025

Watch this live case followed by a live in a box case, regarding a 93-year-old woman with hypertension, chronic bronchitis, and a history of TAVI with a Sapien 3 23 mm (2016) who presented with symptomatic severe aortic stenosis and mildly reduced LV function (50%). An...

Redo TAVI with pre and post dilatation - LIVE Case

Mitral TEER - LIVE Case

16 Nov 2025 – From PCR London Valves 2025

Watch this live case followed by a recorded case, regarding a 75-year-old male with type 2 DM, permanent AF, and severe LV dysfunction (30%), with a history of RCA PCI one month earlier and three hospitalizations for heart failure, presented with severe secondary mitral and tricuspid...

Mitral TEER - LIVE Case

TAVI in challenging anatomical situations

21 May 2025 – From EuroPCR 2025

Delve into the latest advancements in TAVI for challenging anatomical situations. This session features insights from the NORTHOSTAVI registry, transcaval TAVI experiences, early discharge protocols following alternative access, and the application of intravascular lithotripsy to enable safe transfemoral valve replacement.

TAVI in challenging anatomical situations

New devices for structural interventions

21 May 2025 – From EuroPCR 2025

Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.

New devices for structural interventions

Empire one: first-in-human study of a new transcatheter aortic valve system

25 Nov 2024 – From PCR London Valves 2024

Join this roundtable discussion with Nicola Ryan and José Antonio Baz Alonso as they delve into the Empire One trial outcomes. Learn about the IMPERIA™ delivery system for the ALLEGRA™ heart valve, its unique features, and trial results, including detailed hemodynamic findings. Hear insights on its...

Empire one: first-in-human study of a new transcatheter aortic valve system

Featured research - Aortic valve (Part 1)

24 Nov 2024 – From PCR London Valves 2024

Dive into the latest research on aortic valve interventions in this two-part featured research session. Explore a wide range of topics, including the safety and efficacy of novel transcatheter aortic valve systems, hemodynamic outcomes, risk scoring, and peri-procedural considerations.

Featured research - Aortic valve (Part 1)

Double jeopardy: coronary disease in patients undergoing TAVI

17 May 2022 – From EuroPCR 2022

Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...

Double jeopardy: coronary disease in patients undergoing TAVI

Clinical outcomes of ALLEGRA TAVI system in patients with aortic valve disease

23 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to learn about Vivall study outcomes and the use of Allegra in Valve-in-Valve procedures and to focus on single center experience and implantation steps of the Allegra valve.

Clinical outcomes of ALLEGRA TAVI system in patients with aortic valve disease